Reflection Therapeutics

Startup

Reflection Therapeutics is developing targeted anti-inflammatory cell therapies to reduce neuroinflammation at key sites within a patient’s central nervous system. This will protect neurons and increase synaptic connectivity, which will prevent a decline in cognitive function. This therapy will be used to treat ALS and other devastating neurodegenerative diseases